Log in

Relevant bibliographies by topics / Distinct entity / Journal articles

Journal articles on the topic 'Distinct entity'

To see the other types of publications on this topic, follow the link: Distinct entity.

Author: Grafiati

Published: 13 April 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Distinct entity.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Husein El Ahmed, Husein, and Carmen Dulanto-Campos. "A distinct entity." American Journal of Obstetrics and Gynecology 208, no. 1 (January 2013): 89.e1–89.e2. http://dx.doi.org/10.1016/j.ajog.2012.10.864.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gleich, Tobias, Elena Chiticariu, Marcel Huber, and Daniel Hohl. "Keratoacanthoma: a distinct entity?" Experimental Dermatology 25, no. 2 (December 4, 2015): 85–91. http://dx.doi.org/10.1111/exd.12880.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Grof, Paul. "Melancholia: A Distinct Entity?" Canadian Journal of Psychiatry 58, no. 4 (April 2013): 181–82. http://dx.doi.org/10.1177/070674371305800401.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

H. Khaparde, Sadhana, Sanjay D. Deshmukh, Baba B. Shinde, Prajacta Rane, and Shaleen Lamba. "Sialadenoma Papilliferum of Buccal Mucosa : A Rare and Distinct Entity." Indian Journal of Pathology: Research and Practice 5, no. 2 (2016): 219–21. http://dx.doi.org/10.21088/ijprp.2278.148x.5216.28.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Agarwal, Amar, Priya Narang, and DhivyaAshok Kumar. "Predescemetocele: A distinct clinical entity." Indian Journal of Ophthalmology 65, no. 11 (2017): 1224. http://dx.doi.org/10.4103/ijo.ijo_492_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Bomback, Andrew S., and Glen S. Markowitz. "Lupus Podocytopathy: A Distinct Entity." Clinical Journal of the American Society of Nephrology 11, no. 4 (March 16, 2016): 547–48. http://dx.doi.org/10.2215/cjn.01880216.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Joshi, Rajiv, and Yatin Jadhav. "Penoscrotal porokeratosis: A distinct entity." Indian Dermatology Online Journal 6, no. 5 (2015): 339. http://dx.doi.org/10.4103/2229-5178.164487.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Levine, Jimmy, Michael H. Schmidt, Morton I. Burrell, and Michael S. Hopkins. "Acute Jejunoileitis. A Distinct Entity?" Journal of Clinical Gastroenterology 14, no. 1 (January 1992): 47–51. http://dx.doi.org/10.1097/00004836-199201000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Walters, Glenn D. "Dementia: Continuum or distinct entity?" Psychology and Aging 25, no. 3 (2010): 534–44. http://dx.doi.org/10.1037/a0018167.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

McMillan, Marcia J., and R. O. Pihl. "Premenstrual depression: A distinct entity." Journal of Abnormal Psychology 96, no. 2 (1987): 149–54. http://dx.doi.org/10.1037/0021-843x.96.2.149.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Dixon, M. F., H. J. O'Connor, A. T. Axon, R. F. King, and D. Johnston. "Reflux gastritis: distinct histopathological entity?" Journal of Clinical Pathology 39, no. 5 (May 1, 1986): 524–30. http://dx.doi.org/10.1136/jcp.39.5.524.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Pranteda, Bottoni, De Simone, Calvieri, and Grieco. "Bullous keloid: a distinct entity?" British Journal of Dermatology 141, no. 2 (August 1999): 375–77. http://dx.doi.org/10.1046/j.1365-2133.1999.03013.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Yazıcı, Olcay. "Unipolar mania: A distinct entity?" Journal of Affective Disorders 152-154 (January 2014): 52–56. http://dx.doi.org/10.1016/j.jad.2013.10.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Amarapurkar, Anjali D., Deepak Amarapurkar, Mehul Choksi, Nirav Bhatt, and Pooja Amarapurkar. "Portal hypertensive polyps: distinct entity." Indian Journal of Gastroenterology 32, no. 3 (March 20, 2013): 195–99. http://dx.doi.org/10.1007/s12664-013-0324-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Ammann, Roland A., Jack Plaschkes, and Kurt Leibundgut. "Congenital hepatoblastoma: A distinct entity?" Medical and Pediatric Oncology 32, no. 6 (June 1999): 466–68. http://dx.doi.org/10.1002/(sici)1096-911x(199906)32:6<466::aid-mpo20>3.0.co;2-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Korelitz, Burton I., and Jeffrey Aronoff. "Crohnʼs proctitis: A distinct entity." Inflammatory Bowel Diseases 16, no. 5 (May 2010): 721–22. http://dx.doi.org/10.1002/ibd.21089.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Hennekam, R. C. M. "LADD syndrome: a distinct entity?" European Journal of Pediatrics 146, no. 1 (January 1987): 94–95. http://dx.doi.org/10.1007/bf00647303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

LEVINSON, JOSEPH E. "Eosinophilic Fasciitis: A Distinct Entity?" Archives of Pediatrics & Adolescent Medicine 139, no. 1 (January 1, 1985): 8. http://dx.doi.org/10.1001/archpedi.1985.02140030010001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Garg, RavindraKumar, GyanPrakash Singh, Rajiv Garg, Neeraj Kumar, and Anit Parihar. "Severe COVID-19: A distinct entity." Journal of Family Medicine and Primary Care 10, no. 1 (2021): 84. http://dx.doi.org/10.4103/jfmpc.jfmpc_1600_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Pawar, Vipul Mohan. "Verruciform Xanthoma-Histopathologically: A Distinct Entity." Journal of Contemporary Dentistry 4, no. 3 (2014): 181–84. http://dx.doi.org/10.5005/jp-journals-10031-1093.

Full text

Abstract:

ABSTRACT Verruciform xanthoma (VX) is an uncommon benign mucocutaneous lesion of unknown etiology. It is essential to diagnose this lesion as a varied entity of utmost importance as clinically their appearance could range from a simple leukoplakia or papilloma to as grave as squamous cell carcinoma SCC. Although this lesion is of multifactorial pathogenesis, a viral etiology like human papilloma virus (HPV) has been suggested in some cases. This rare, harmless lesion usually presents as a sessile or pedunculated, pale yellowish-to-red, papillary, granular or verrucous mucosal growth. Histopathologically, VX is characterized by the presence of parakeratinzed epithelium showing papillary or verrucous growth with thin rete ridges and connective tissue papillae extending up to the surface. The papillae characteristically consist of foam cells, also called xanthoma cells. We report two cases of VX of varied clinical appearance but very similar and characteristic histopathological presentation to be diagnosed as VX. The clinical diagnosis, though may be challenging; the histopathological features are diagnostic and well-defined. It is also noteworthy that in an improper biopsy, xanthoma cells may be scanty and their presence can be missed, especially if one is unfamiliar with the existence of this lesion. How to cite this article Pawar VM, Patel S, Pathak J, Swain N. Verruciform Xanthoma-Histopathologically: A Distinct Entity. J Contemp Dent 2014;4(3):181-184.

APA, Harvard, Vancouver, ISO, and other styles

21

Ray, Katrina. "Eosinophilic colitis — a distinct clinical entity?" Nature Reviews Gastroenterology & Hepatology 19, no. 3 (February 1, 2022): 148. http://dx.doi.org/10.1038/s41575-022-00583-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Kansal, NaveenKumar, C. Divyalakshmi, and Aditi Dhanta. "Lichenoid psoriasis: A distinct morphological entity." Clinical Dermatology Review 4, no. 1 (2020): 67. http://dx.doi.org/10.4103/cdr.cdr_15_19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Morris, Gabrielle F., Katrina Murphy, Lucy B. Rorke, and Hector E. James. "Spinal hamartomas: a distinct clinical entity." Journal of Neurosurgery 88, no. 6 (June 1998): 954–61. http://dx.doi.org/10.3171/jns.1998.88.6.0954.

Full text

Abstract:

Object. Congenital spinal hamartomas are defined as tumors of well-differentiated mature elements situated in an abnormal location. In this report, the authors document the clinical and pathological features of spinal hamartomas in 10 patients. Methods. Ten patients presented with midline dorsal malformations at birth, initially diagnosed as teratomas or myelomeningoceles. The locations of the masses were variable: two were located in the thoracic region, four at the thoracolumbar junction, two in the lumbar region, one at the lumbosacral junction, and one in the sacral region. The results of the neurological examination were normal in nine patients. All but one mass had intact skin and seven had palpable bone components. Neuroimaging studies revealed widening of the spinal canal, heterotopic bone located dorsally in some patients, and varying degrees of involvement of the intraspinal contents. During surgery, six patients were found to have involvement of the spinal cord or cauda equina. The pathological characteristics of the masses included three or more of the following: bone, cartilage, synovial membrane, urinary tract tissue, cyst wall, yellow or brown fat, and nerves. The well-differentiated cellular elements, which formed mature structures, along with the absence of primitive cellular components and neoplastic characteristics are more consistent with a diagnosis of hamartoma than teratoma. Conclusions. In this series, the authors describe a lesion that is overt on physical examination, yet can have occult spinal canal involvement. Complete neurosurgical evaluation is essential to provide appropriate treatment and prognosis.

APA, Harvard, Vancouver, ISO, and other styles

24

Wasserfallen, Jean-Blaise, Marie-Denise Schaller, Francois Feihl, and Claude H. Perret. "Sudden Asphyxic Asthma: A Distinct Entity?" American Review of Respiratory Disease 142, no. 1 (July 1990): 108–11. http://dx.doi.org/10.1164/ajrccm/142.1.108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Strong, Russell W. "DIEULAFOY'S DISEASE-A DISTINCT CLINICAL ENTITY." Australian and New Zealand Journal of Surgery 54, no. 4 (January 21, 2008): 337–39. http://dx.doi.org/10.1111/j.1445-2197.1984.tb05329.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Sabatelli, M., F. Madia, L. De Armas, and P. Tonali. "PURE MOTOR CIDP. A DISTINCT ENTITY?" Journal of the Peripheral Nervous System 5, no. 1 (March 2000): 49. http://dx.doi.org/10.1046/j.1529-8027.2000.00513-52.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

FLETCHER, C. D. M., S. E. DAVIES, and P. H. MCKEE. "Cellular schwannoma: a distinct pseudosarcomatous entity." Histopathology 11, no. 1 (April 3, 2007): 21–35. http://dx.doi.org/10.1111/j.1365-2559.1987.tb02606.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Gertz, Morie A., Francis K. Buadi, Suzanne R. Hayman, David Dingli, Angela Dispenzieri, Philip R. Greipp, Shaji K. Kumar, et al. "Immunoglobulin D amyloidosis: a distinct entity." Blood 119, no. 1 (January 5, 2012): 44–48. http://dx.doi.org/10.1182/blood-2011-06-358895.

Full text

Abstract:

Abstract IgD monoclonal gammopathies are uncommon. They are seen rarely as a monoclonal gammopathy of undetermined significance and are present in 1%-2% of patients with multiple myeloma. In light-chain amyloidosis, IgD monoclonal proteins are found in ap-proximately 1% of patients. When an IgD monoclonal protein is found, amyloidosis is often omitted from the differential diagnosis. In the present study, we reviewed the natural history of IgD-associated amyloidosis among 53 patients seen over 41 years. The distribution of clinical syndromes suggests that these patients have a lower frequency of renal and cardiac involvement. The overall survival of these patients does not appear to be different from that of patients who have light-chain amyloidosis associated with another monoclonal protein.

APA, Harvard, Vancouver, ISO, and other styles

29

van der Meijden, Willem I., and Patricia C. Ewing. "Papular Colpitis: A Distinct Clinical Entity?" Journal of Lower Genital Tract Disease 15, no. 1 (January 2011): 60–65. http://dx.doi.org/10.1097/lgt.0b013e3181dc2f6a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Amarapurakar, Deepak, Anjali D. Amarapurkar, Nirav Bhatt, Mehul J. Choksi, and Pooja Amarapurkar. "Su1959 Portal Hypertensive Polyps: Distinct Entity." Gastroenterology 142, no. 5 (May 2012): S—546. http://dx.doi.org/10.1016/s0016-5085(12)62098-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Oliver, G. Fergus, and R. K. Winkelmann. "Unilesional mycosis fungoides: A distinct entity." Journal of the American Academy of Dermatology 20, no. 1 (January 1989): 63–70. http://dx.doi.org/10.1016/s0190-9622(89)70008-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Smith, Dr Molly, Dr Craig Fowler, Dr Indraneel Bhattacharyya, Dr Rekha Reddy, and Dr Douglas Damm. "AMELOBLASTIC fiBRO-ODONTOMA: A DISTINCT ENTITY." Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 128, no. 1 (July 2019): e89. http://dx.doi.org/10.1016/j.oooo.2019.02.227.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Dhondt, E., L. Oudenhoven, S. Khan, H. M. Kroon, P. C. Hogendoorn(•), A. Nieborg, J. L. Bloem, and A. De Schepper. "Nora’s lesion, a distinct radiological entity?" Skeletal Radiology 35, no. 7 (April 7, 2006): 497–502. http://dx.doi.org/10.1007/s00256-005-0041-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Hyser, Craig L., John T. Kissel, John R. Warmolts, and Jerry R. Mendell. "Scapuloperoneal neuropathy: A distinct clinicopathologic entity." Journal of the Neurological Sciences 87, no. 1 (October 1988): 91–102. http://dx.doi.org/10.1016/0022-510x(88)90057-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Mori, Makoto, Robert W. Elder, and Wendy M. Book. "Adult Fontan failure — Distinct disease entity." International Journal of Cardiology 177, no. 2 (December 2014): 650. http://dx.doi.org/10.1016/j.ijcard.2014.09.177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Krutchkoff, David J., and Ellen Eisenberg. "Lichenoid dysplasia: A distinct histopathologic entity." Oral Surgery, Oral Medicine, Oral Pathology 60, no. 3 (September 1985): 308–15. http://dx.doi.org/10.1016/0030-4220(85)90315-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Bitton, Rachelle N., and Craig Wexler. "Free triiodothyronine toxicosis: A distinct entity." American Journal of Medicine 88, no. 5 (May 1990): 531–33. http://dx.doi.org/10.1016/0002-9343(90)90435-g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Sakata, Shigeki, and Toru Ogawa. "Free T3 toxicosis: A distinct entity?" American Journal of Medicine 91, no. 1 (July 1991): 100. http://dx.doi.org/10.1016/0002-9343(91)90083-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Behranwala, K. A., and J. M. Thomas. "‘Aggressive’ angiomyxoma: a distinct clinical entity." European Journal of Surgical Oncology (EJSO) 29, no. 7 (September 2003): 559–63. http://dx.doi.org/10.1016/s0748-7983(03)00104-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Van Borsel, John, Sandie Van Der Made, and Patrick Santens. "Thalamic stuttering: A distinct clinical entity?" Brain and Language 85, no. 2 (May 2003): 185–89. http://dx.doi.org/10.1016/s0093-934x(03)00061-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Weatherald, Jason, Peter Dorfmüller, Frédéric Perros, Maria-Rosa Ghigna, Barbara Girerd, Marc Humbert, and David Montani. "Pulmonary capillary haemangiomatosis: a distinct entity?" European Respiratory Review 29, no. 156 (May 27, 2020): 190168. http://dx.doi.org/10.1183/16000617.0168-2019.

Full text

Abstract:

Pulmonary capillary haemangiomatosis (PCH) is a rare and incompletely understood histopathological finding characterised by abnormal capillary proliferation within the alveolar interstitium, which has long been noted to share many overlapping features with pulmonary veno-occlusive disease (PVOD). But are PCH and PVOD distinct entities that occur in isolation, or are they closely intertwined manifestations along a spectrum of the same disease? The classic clinical features of both PCH and PVOD include signs and symptoms related to pulmonary hypertension, hypoxaemia, markedly impaired diffusion capacity of the lung and abnormal chest imaging with ground glass opacities, septal lines and lymphadenopathy. In recent years, increasing evidence suggests that the clinical presentation, histopathological features, genetic substrate and pathobiological mechanisms of PCH and PVOD are overlapping and usually indistinguishable. The discovery of biallelic mutations in the eukaryotic translation initiation factor 2 α kinase 4 (EIF2AK4) gene in heritable PCH and PVOD greatly advanced our understanding of the overlapping nature of these conditions. Furthermore, recognition of PCH and PVOD-like changes in other pulmonary vascular diseases and in conditions that cause chronic pulmonary venous hyper-perfusion or hypertension suggests that PCH/PVOD may develop as a reactive process to various insults or injuries to the pulmonary vasculature, rather than being primary angiogenic disorders.

APA, Harvard, Vancouver, ISO, and other styles

42

Steensma, David P., Curtis A. Hanson, Louis Letendre, and Ayalew Tefferi. "Myelodysplasia with fibrosis: a distinct entity?" Leukemia Research 25, no. 10 (October 2001): 829–38. http://dx.doi.org/10.1016/s0145-2126(01)00055-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Durrani, Khayyam, and C. Stephen Foster. "Psoriatic uveitis: A distinct clinical entity?" American Journal of Ophthalmology 139, no. 1 (January 2005): 106–11. http://dx.doi.org/10.1016/j.ajo.2004.08.053.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Mackworth-Young, Charles. "Primary antiphospholipid syndrome: A distinct entity?" Autoimmunity Reviews 5, no. 1 (January 2006): 70–75. http://dx.doi.org/10.1016/j.autrev.2005.08.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Cohen, Pierre Alain, G. Kalifa, Veronica Donoghue, Catherine Adamsbaum, Faddy Haddad, and Jean Dubousset. "Ischio-vertebral dysplasia: a distinct entity." Pediatric Radiology 29, no. 2 (January 29, 1999): 131–34. http://dx.doi.org/10.1007/s002470050556.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Shin, Jung-Ha, Tae-Eun Kim, Kyo-Young Lee, Sang-In Shim, and Yeong-Jin Choi. "C1q Nephropathy: A Distinct Pathologic Entity." Korean Journal of Pathology 43, no. 4 (2009): 335. http://dx.doi.org/10.4132/koreanjpathol.2009.43.4.335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Kumar, Bhushan, and Davinder Parsad. "Is ‘Nodular Tuberculid’ A Distinct Entity?" Pediatric Dermatology 18, no. 2 (March 2001): 165–66. http://dx.doi.org/10.1046/j.1525-1470.2001.01894-3.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Kokal, William A., L. Robert Hill, David Porudominsky, J. David Beatty, M. Margaret Kemeny, Daniel U. Riihimaki, and Ose J. Terz. "Inflammatory breast carcinoma: A distinct entity?" Journal of Surgical Oncology 30, no. 3 (July 19, 2006): 152–55. http://dx.doi.org/10.1002/jso.2930300306.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Roach, E. S. "Is Neuromyelitis Optica a Distinct Entity?" Archives of Neurology 64, no. 6 (June 1, 2007): 906. http://dx.doi.org/10.1001/archneur.64.6.906.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Gulia, Joyti, Shambu Aryal, Haval Saadlla, and Andrew F. Shorr. "Healthcare-associated candidemia-A distinct entity?" Journal of Hospital Medicine 5, no. 5 (June 9, 2010): 298–301. http://dx.doi.org/10.1002/jhm.652.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!